(a) The privacy protections provided an individual under Title 21, Code of Federal Regulations, §1314.45, apply to information entered or stored in a real-time electronic logging system.
(b) A business establishment that engages in over-the-counter sales of a product containing ephedrine, pseudoephedrine, or norpseudoephedrine may disclose information entered or stored in a real-time electronic logging system only to the United States Drug Enforcement Administration and other federal, state, and local law enforcement agencies.
(c) A business establishment that engages in over-the-counter sales of a product containing ephedrine, pseudoephedrine, or norpseudoephedrine may not use information entered or stored in a real-time electronic logging system for any purpose other than for a disclosure authorized by subsection (b) of this section or to comply with the requirements of this subchapter.

Source Note: The provisions of this §230.18 adopted to be effective October 11, 2012, 37 TexReg 8032